Who has invested in Travere Therapeutics?

No investors are named on the public record for Travere Therapeutics yet.

Travere Therapeutics Funding: $230M Raised

Travere Therapeutics funding overview

Travere Therapeutics has raised $230M in total disclosed funding. That places its disclosed total in the $100M–$250M range. The round record for Travere Therapeutics runs through 2023; nothing later has been disclosed.

Travere Therapeutics at a glance

Total raised: $230M
Latest round date: January 2023

Frequently asked about Travere Therapeutics funding

How much has Travere Therapeutics raised?: Travere Therapeutics has raised $230M in total disclosed funding across the rounds on record.
Who has invested in Travere Therapeutics?: No investors are named on the public record for Travere Therapeutics yet.
What was the latest Travere Therapeutics funding round?: No round stage has been disclosed for Travere Therapeutics.
Where is Travere Therapeutics based?: No headquarters location is disclosed for Travere Therapeutics.
When did Travere Therapeutics last raise?: The last disclosed Travere Therapeutics round closed in January 2023.

Round data for Travere Therapeutics is compiled from public filings and announcements; blank fields mean nothing has been disclosed rather than nothing exists. Continue with the companies and backer lists below.

Travere Therapeutics Funding: $230M Raised

Travere Therapeutics funding overview

Travere Therapeutics at a glance

Frequently asked about Travere Therapeutics funding

Companies related to Travere Therapeutics (30)

Browse related funding lists (2)